Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 1/20 | 0.43 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.41 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10044994 | 0.87 | IDO1 (0.55) | IDO1 | |
| SCHEMBL766905 | 0.86 | SMN1; SMN2 (0.44) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL3036323 | 0.81 | CA1 (0.47) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL13755963 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL10356058 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL251775 | 0.81 | IDO1 (0.40) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL8679722 | 0.79 | SMN1; SMN2 (0.44) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL8101238 | 0.79 | SMN1; SMN2 (0.40) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL9185281 | 0.79 | IDO1 (0.42) | SMN1; SMN2CA1CA2CA9IDO1 | |
| SCHEMBL27927410 | 0.79 | SMN1; SMN2 (0.44) | SMN1; SMN2CA1CA2CA9IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10703959-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES, A GE COMPANY, LLC (US) | 2020-07-07 | — | — | US | disclosed |
| EP-2800549-B1 | AQUEOUS COSMETIC COMPOSITION COMPRISING ALKYLCELLULOSE, NON-VOLATILE OILS, AT LEAST ONE WAX AND AT LEAST ONE GEMINI SURFACTANT | OREAL (FR) | 2018-01-24 | — | — | EP | disclosed |
| US-20170247599-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED | 2017-08-31 | — | — | US | disclosed |
| US-9683163-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES INCORPORATED (US) | 2017-06-20 | — | — | US | disclosed |
| WO-2016149454-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2016-09-22 | — | — | WO | disclosed |
| US-20150191646-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2015-07-09 | — | — | US | disclosed |
| US-9012377-B2 | Functionalized silicate nanoparticle composition, removing and exfoliating asphaltenes with same | BAKER HUGHES INCORPORATED (US) | 2015-04-21 | — | — | US | disclosed |
| WO-2014106007-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | WO | disclosed |
| US-20140187449-A1 | FUNCTIONALIZED SILICATE NANOPARTICLE COMPOSITION, REMOVING AND EXFOLIATING ASPHALTENES WITH SAME | BAKER HUGHES INCORPORATED (US) | 2014-07-03 | — | — | US | disclosed |
| US-8197903-B2 | Surface modified organic inorganic hybrid glass, protecting group induced alcohol or its derivative and producing method thereof | INDUSTRY-ACADEMIC COOPERATION FOUNDATION YONSEI UNIVERSITY (KR) | 2012-06-12 | — | — | US | disclosed |
| US-20090274910-A1 | Surface Modified Organic Inorganic Hybrid Glass, Protecting Group Induced Alcohol or Its Derivative and Producing Method Thereof | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2009-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090274910-A1 | Surface Modified Organic Inorganic Hybrid Glass, Protecting Group Induced Alcohol or Its Derivative and Producing Method Thereof | VIM, ICAM1, ILK | SMN1; SMN2 3807/4885CA1 359/4885CA2 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.